SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-036596
Filing Date
2024-03-26
Accepted
2024-03-26 17:25:07
Documents
11
Period of Report
2024-03-26
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 8-K lbph-20240326.htm   iXBRL 8-K 44311
  Complete submission text file 0000950170-24-036596.txt   173072

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lbph-20240326.xsd EX-101.SCH 32543
14 EXTRACTED XBRL INSTANCE DOCUMENT lbph-20240326_htm.xml XML 5112
Mailing Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 950 LA JOLLA CA 92037 619-592-9775
Longboard Pharmaceuticals, Inc. (Filer) CIK: 0001832168 (see all company filings)

IRS No.: 845009619 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40192 | Film No.: 24784800
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)